BROADCASTS.com

b'Every week, The American Journal of Managed Care\\xae\\xa0(AJMC\\xae) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\\n\\nThis week, the top managed care news included\\xa0House and Senate hearings on the cost of prescription drugs;\\xa0a\\xa0study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of\\xa0chronic lymphocytic leukemia.\\n\\nRead more about the stories in this podcast:\\nSenate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions\\nMedicare Patients With Type 2 Diabetes Safely Switched From Analog to Human Insulin, JAMA Study Finds: https://www.ajmc.com/newsroom/medicare-patients-with-type-2-diabetes-safely-switched-from-analog-to-human-insulin-ijamai-study-finds\\nFDA Approves Ibrutinib Combination as Frontline Treatment for CLL: https://www.ajmc.com/newsroom/fda-approves-ibrutinib-combination-as-frontline-treatment-for-cll\\nWhat Do Americans Think About Medicare for All? It Depends on What They Hear: https://www.ajmc.com/focus-of-the-week/what-do-americans-think-about-medicare-for-all-it-depends-on-what-they-hear\\nCongress Doubles Down on High Drug Prices, but Is It More Talk Than Action? https://www.ajmc.com/focus-of-the-week/congress-doubles-down-on-high-drug-prices-but-is-it-more-talk-than-action\\nThe Drug Price Iceberg: More Than Meets the Eye: https://www.ajmc.com/journals/issue/2019/2019-vol25-n2/the-drug-price-iceberg-more-than-meets-the-eye'